Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Neuro-Oncology
Metadata
Title
Correction to: Prognostic factors analysis of diffuse midline glioma
Authors
Jing Jiang
Wen-bin Li
Shao-wen Xiao
Publication date
15-03-2024
Publisher
Springer US
Published in
Journal of Neuro-Oncology / Issue 2/2024
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-024-04634-1

Other articles of this Issue 2/2024

Journal of Neuro-Oncology 2/2024 Go to the issue

Research

Hypofractionated stereotactic re-irradiation for progressive glioblastoma: twelve years’ experience of a single center

Case Study

Virtual multi-institutional tumor board: a strategy for personalized diagnoses and management of rare CNS tumors

Case Study

Imaging as an early biomarker to predict sensitivity to everolimus for progressive NF2-related vestibular schwannoma

Correspondence

Harnessing imaging biomarkers for glioblastoma metastasis diagnosis: a correspondence

Research

Palliative care for in-patient malignant glioma patients in Germany

Correspondence

Letter to the editor: Dexamethasone and overall survival and progression free survival in patients with newly diagnosed glioblastoma: a meta-analysis